Intelligent Bio Solutions (INBS) executive compensation, 2025 proxy

Harry Simeonidis, Chief Executive Officer & President, was paid $482,671 in 2025, up 8% from $446,622 the year before.

Filed
September 19, 2025
Annual meeting
October 16, 2025
Pay year
2025
Named executives
2
CEO total pay
$482,671+8% vs prior year
CEO pay in equity
12%$56,945 in awards
CEO stock award
$56,9452019 Long Term Incentive Plan
CFO stock award
$49,1152019 Long Term Incentive Plan
Maximum annual bonus
20%Of respective base salary
CEO new base salary
$379,900Effective June 30, 2025
CFO new base salary
$281,650Effective June 30, 2025
2019 Plan shares
1,300,000Current shares subject to plan

How Simeonidis was paid

$482,671 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary76%Stock awards12%All other compensation12%

Named executive officers

ExecutiveTotal
Harry SimeonidisChief Executive Officer & President$482,671
Spiro SakirisChief Financial Officer$363,532

What changed and why

  • $483K$482,671 CEO total compensation in 2025, up from $446,622 in 2024.
  • $56,945$56,945 CEO stock compensation was granted under the 2019 Long Term Incentive Plan.
  • $364K$363,532 CFO total compensation included $49,115 in stock compensation.
  • 20%20% of base salary is the maximum annual bonus opportunity for each executive.
  • June 30, 2025 amendments added enhanced severance and immediate full vesting after termination without cause.
  • $380K$379,900 became the CEO’s annual base salary and $281,650 became the CFO’s annual base salary.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.